Amneal Pharmaceuticals (AMRX): Rasio rega marang prakiraan pendapatan

Amneal Pharmaceuticals Inc (AMRX) - logo korporat

Amneal Pharmaceuticals (AMRX) is implementing ESG principles by reducing harmful emissions and water consumption. The future P/S dynamics for Amneal Pharmaceuticals on this GURU.Markets chart show that the parameter reaches 0.70. Business efficiency relies on optimized ground delivery of medications and a stable staff of high-class chemical technologists who ensure the development of the biosimilar portfolio.

AMRX amneal.com: Kapitalisasi marang prakiraan pendapatan ing interval 04.07.2022 - 17.11.2026

Rincian metrik lan analitis perusahaan amneal.com (AMRX)

Ringkesan analitik perusahaan:Amneal Pharmaceuticals Inc (AMRX)
Sampel barang Amneal Pharmaceuticals

For Amneal Pharmaceuticals (AMRX), the current forward P/S ratio reflects market expectations for capitalization relative to projected revenue, confirming the effectiveness of scaling through the automation of generic drug production. This indicator measures the business's fundamental margin of safety, demonstrating the company's ability to maintain asset value amid changes in tax regimes or demand for specialized medications.

Pesaing wigati

Multiplikator Forward P/S HLN (Haleon PLC)|Multiplikator Forward P/S Kenvue Corp KVUE|Verona Pharma PLC - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep jyongbio.com|LGND: Multiplikator Forward P/S|Perrigo Company PLC - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan alvotech.com|Multiplikator Forward P/S Liquidia Technologies|Rasio rega marang prakiraan pendapatan Galapagos Genomics (GLPG)|ANIP: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S MNKD (MannKind Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Amphastar (AMPH)|PCRX: Multiplikator forward rega marang pendapatan|SPRY - Multiplikator Forward P/S|Theravance Biopharma, Inc. (TBPH) - Rasio rega marang prakiraan pendapatan|AQST (Aquestive Therapeutics) - Rasio rega marang prakiraan pendapatan|SCPH (scpharmaceuticals.com) - Multiplikator Forward P/S|TECX: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S EPRX (Eupraxia Pharmaceuticals)|Rega forward marang dodolan BHST|Invizyne Technologies - Multiplikator Forward P/S|oramed.com (ORMP) - Multiplikator forward rega marang pendapatan|ENTX (enterabio.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan HYFT|ABVC (ABVC BioPharma, Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S cumberlandpharma.com|Rasio rega marang prakiraan pendapatan Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prakiraan rega marang pendapatan|Multiplikator Forward P/S TELO (telomirpharma.com)|RANI - Multiplikator forward rega marang pendapatan|SNYR - Rasio rega marang prakiraan pendapatan|rallybio.com - Rasio rega marang pendapatan sing dikarepake|LEXX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pulmatrix Inc|PTHL (Pheton Holdings) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aptorum Group Limited APM|Rasio rega marang prakiraan pendapatan Lyra Therapeutics (LYRA)|Multiplikator forward rega marang pendapatan Impact BioMedical Inc IBO|Rasio rega marang prakiraan pendapatan tnfpharma.com TNFA|Rega forward marang dodolan YCBD|PainReform Ltd - Multiplikator Forward P/S|Altamira Therapeutics Ltd (CYTO) - Multiplikator forward rega marang pendapatan|lipella.com (LIPO) - Rasio rega marang prakiraan pendapatan|OptiNose (OPTN) - Multiplikator Forward P/S|PIRS (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|PROC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Petros Pharmaceuticals, Inc. (PTPI)|Multiplikator Forward P/S Qilian International Corp (QLI)|ACELYRIN, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S tffpharma.com TFFP